Tocilizumab in COVID-19 Treatment: A Cost-Burden in Low- and Middle-Income Countries
Author | Md Jahidul Hasan | en |
Orcid | Md Jahidul Hasan [0000-0001-7038-6437] | en |
Issued Date | 2020-05-16 | en |
Abstract | This article does not have an abstract. | en |
DOI | https://doi.org/10.5812/ijhls.104480 | en |
Publisher | Brieflands | en |
Title | Tocilizumab in COVID-19 Treatment: A Cost-Burden in Low- and Middle-Income Countries | en |
Type | Letter | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijhls-6-2-104480.pdf
- Size:
- 78.13 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF